Tesamorelin
Also known as Tesamorlin · EGRIFTA · TH9507
Stabilized GHRH analog — A 44-amino-acid GHRH analog that stimulates pituitary GH secretion, studied for visceral adipose-tissue reduction in research.
Latest released COA: 98.165%Lyophilized powder
From $72.99In stock
View purchase options
Specifications
| CAS number | 218949-48-5 |
|---|
| Molecular formula | C221H366N72O67S |
|---|
| Molecular weight | 5135.86 g/mol |
|---|
| Form | Lyophilized powder |
|---|
Research use only. Not for human or veterinary use, consumption, diagnosis, treatment, or therapeutic purposes.
Documentation
Certificates of Analysis
Batch-specific, third-party lab certificates. Each COA is published here once its lot has been tested — preview the results, then open the full PDF.
Research context
Tesamorelin research, identity and references
Also known as Tesamorlin, EGRIFTA, TH9507
How is tesamorelin characterized in research?
Tesamorelin is a stabilized growth-hormone-releasing-hormone analog. These references identify its research class and analytical context; they do not constitute directions for use or evidence about an Astral lot.
CAS number218949-48-5
Molecular formulaC221H366N72O67S
Molecular weight5135.86 g/mol
Sequence44-amino-acid GHRH analog (trans-3-hexenoyl)
Analytical review
Analytical review
Memdouh S, Gavrilović I, Ng K, et al. Drug Testing and Analysis (2021).
Discusses identification and detection of synthetic GHRH analogs, including the analytical identity boundary.
PMID 34665524 · DOI 10.1002/dta.3183
Editorially curated and source-verified; not independently peer-reviewed by Astral. Last source check: 2026-08-04. How sources are selected.
Check released lot evidence →